pMM288
(Plasmid
#46036)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 46036 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBI
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 4400
- Total vector size (bp) 11707
-
Modifications to backboneinsertion of polylinker containing Bsp1D1 and XhoI sites
-
Vector typeMammalian Expression ; TRE, bidirectional promoter
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameWRN E84A
-
Alt nameWerner syndrome, RecQ helicase-like
-
Alt nameRECQ3
-
Alt nameRECQL2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)4514
-
MutationE84A exonuclease-dead mutant; S2G introduced during cloning
-
GenBank IDNM_000553.4
-
Entrez GeneWRN (a.k.a. RECQ3, RECQL2, RECQL3)
- Promoter CMV2
-
Tag
/ Fusion Protein
- 5x myc (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BspD1 (not destroyed)
- 3′ cloning site Xho1 (not destroyed)
- 5′ sequencing primer Unknown (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Bidirectional vector expresses WRN and GFP at similar expression levels. In the associated article, cells were transiently transfected with this plasmid together with a tTA transactivator plasmid (Gossen, 1992).
This is a mammalian expression vector for human WRN protein that lacks exonuclease activity by virtue of an E84A substitution. It was constructed from pBI, a Clontech plasmid with a bi-directional promoter+ TRE backbone, modified by insertion of a polylinker containing BspD1 and Xhol sites and a myc-WRN E84A ORF- created by making E84A (A>C) mutation in pMM290 sequence.
The S2G mutation was a result of the cloning strategy to add the myc tag. The WRN protein containing S2G was biochemically verified and is wild-type in terms of activities, as described in the associated publication.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMM288 was a gift from Raymond Monnat (Addgene plasmid # 46036 ; http://n2t.net/addgene:46036 ; RRID:Addgene_46036) -
For your References section:
The Werner syndrome protein has separable recombination and survival functions. Swanson C, Saintigny Y, Emond MJ, Monnat RJ Jr. DNA Repair (Amst). 2004 May 4;3(5):475-82. 10.1016/j.dnarep.2004.01.002 PubMed 15084309